Market revenue in 2022 | USD 455.7 million |
Market revenue in 2030 | USD 1,103.9 million |
Growth rate | 11.7% (CAGR from 2022 to 2030) |
Largest segment | Polyvinyl chloride (pvc) |
Fastest growing segment | Polypropylene (PP) |
Historical data | 2019 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Polyethylene (PE), Polypropylene (PP), Acrylonitrile Butadiene Styrene (ABS), Polyethylene Terephthalate (PET), Polyvinyl Chloride (PVC), Polytetrafluoroethylene (PTFE), Polycarbonate (PC), Other |
Key market players worldwide | Basf SE, LyondellBasell Industries NV Class A, SABIC, LG Chem, Toray Industries Inc, Solvay SA, Dow Inc, DuPont de Nemours Inc, Compagnie de Saint-Gobain SA, Tekni-Plex, Chevron Corp, Exxon Mobil Corp, Covestro AG, Teijin Ltd, Mitsui Chemicals Inc, Formosa Plastics Group, CHIMEI |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharma plastics market will help companies and investors design strategic landscapes.
Polyvinyl chloride (pvc) was the largest segment with a revenue share of 21.81% in 2024. Horizon Databook has segmented the U.S. biopharma plastics market based on polyethylene (pe), polypropylene (pp), acrylonitrile butadiene styrene (abs), polyethylene terephthalate (pet), polyvinyl chloride (pvc), polytetrafluoroethylene (ptfe), polycarbonate (pc), other covering the revenue growth of each sub-segment from 2019 to 2030.
Key initiatives such as the Affordable Care Act (ACA) and Medicaid undertaken by the Government of the U.S. have enabled a large percentage of the population of the country to have access to effective and improved healthcare facilities and services.
This has fueled the demand for branded drugs, medical devices, and healthcare services in the U.S., thereby driving the consumption of biopharma plastics in the country for developing disposable medical connectors, syringes, depth filters, etc.
According to the American Cancer Society (ACS), breast cancer is the most common cancer that affects women in the U.S. It usually occurs in middle-aged and old women. The use of hormone therapy for the treatment of menopausal symptoms elevates estrogen levels in women. This is one of the major causes of breast cancer in women.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. biopharma plastics market , including forecasts for subscribers. This country databook contains high-level insights into U.S. biopharma plastics market from 2019 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account